Le site des Doctorants

De la Faculté de Médecine de l'ULB

Publis2006

 

 

La mise à jour de cette rubrique dépend de vous ! Envoyez-moi les références de vos publications.

doc7 This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

Arsenijevic T, Degraef C, Dumont JE, Roger PP, Pirson I.
G1/S Cyclins interact with regulatory subunit of PKA via A-kinase anchoring protein, AKAP95.
Cell Cycle 5, 1217-1222, 2006.

Bearzatto B, Servais L, Roussel C, Gall D, Baba-Aïssa F, Schurmans S, de Kerchove A, Cheron G, Schiffmann SN.
Targeted calretinin expression in granule cells of calretinin-null mice restores normal cerebellar functions. 
FASEB J.; 20:380-382, 2006.

Blanpain C, Fuchs E.
Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22, 339-373, 2006.

Blanpain C, Lowry WE, Pasolli HA, Fuchs E.
Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 20, 3022-3035, 2006.
 
Bockstaele L, Kooken H, Libert F, Paternot S, Dumont JE, De Launoit Y, Roger PP, Coulonval K.
Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4, CDK4: its relationship with cyclins and CDK "inhibitors".
Mol Cell Biol 26, 5070-5085, 2006.
 
Bockstaele L, Coulonval K, Kooken H, Paternot S, Roger, PP.
Regulation of CDK4 (invited review).
Cell Div (BioMed Central http://www.celldiv.com/content/1/1/25) 1, 25, 2006.

Cheong SC, Blangenois I, Franssen JD, Servais C, Phan V, Trakatelli M, Bruyns C, Vile R, Velu T, Brandenburger A.
Generation of cell hybrids via a fusogenic cell line.
J Gene Med 8, 919-928, 2006.

CHICO GALDO V, MASSART C, JIN L, VANVOOREN V, CAILLET-FAUQUET P, ANDRY G, LOTHAIRE P, DEQUANTER D, FRIEDMAN M, VAN SANDE J.
Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures.
Mol Cell Endocrinol. 2006; 257–258:6–14.
 
Corazza F, Hermans C, D'Hondt S, Ferster A, Kentos A, Benoit Y, Sariban E.
Circulating thrombopoietin as an in vivo growth factor for blast cells in acute myeloid leukemia.
Blood.;107(6):2525-30, 2006.
 
De Leener A, Montanelli L, Van Durme J, Chae H, Smits G, Vassart G, Costagliola S.
Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.
J Clin Endocrinol Metab.; 91(2):555-62, 2006.

Delbaere A, Smits G, Vassart G, Costagliola S.
Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.
Nat Clin Pract Endocrinol Metab 2, 590-591, 2006.

Dessars B, Heimann P, Swillens S, El Housni H.
Limitations and practical procedure in BclII-Ig heavy chain gene rearrangement real-time quantitative polymerase chain reaction.
J Mol Diagn 8, 133-136, 2006.

Dufour A, Seibt J, Passante L, Depaepe V, Ciossek T, Frisen J, Kullander K,Flanagan JG, Polleux F, Vanderhaeghen P.
Gene Exp Patterns.; 6(4):353-9, 2006.
 
El Zein N, Badran BM, Sariban E.
The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway.
Cell Signal.;19(1):152-162, 2006.

El Zein N, Corazza F, Sariban E.
The neuropeptide pituitary adenylate cyclase activating protein is a physiological activator of human monocytes.
Cell Signal.; 18(2):162-73, 2006.
 
Horckmans M, Marcet B, Marteau F, Bulte F, Maho A, Parmentier M, Boeynaems JM, Communi D.
Extracellular adenine nucleotides inhibit the release of major monocyte
recruiters by human monocyte-derived dendritic cells.
FEBS Lett.; 580(3):747-54, 2006. 
 
Horckmans M, Marcet B, Marteau F, Bulte F, Maho A, Parmentier M, Boeynaems JM, Communi D.
Extracellular adenine nucleotides inhibit the release of major monocyte recruiters by human monocyte-derived dendritic cells.
FEBS Lett.; 580(3):747-54, 2006.

Langlet C, Nachtergael I, Robberecht P and Langer I.
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized recept.
Peptides.; 27(7):1865-1870, 2006.   

Markessis E, Poncelet L, Colin C, Coppens A, Hoonhorst I, Deggouj N, Deltenre P.
Auditory steady-state evoked potentials (ASSEPs): A study of optimal stimulation parameters for frequency-specific threshold measurements in dogs.
Clinical Neurophysiolology ;117:1760-1771, 2006.

Markessis E, Kapadia S, Munro KJ, Moore BCJ.
Modification of the Threshold Equalising Noise (TEN) test for cochlear dead regions for use with steeply sloping high-frequency hearing loss
International Journal of Audiology ;45:91-98, 2006.

Mendive F, Laurent P, Van Schoore G, Skarnes W, Pochet R, Vassart G.
Defective postnatal development of the male reproductive tract in LGR4 knockout mice. Dev Biol 290, 421-434, 2006.

Migeotte I, Communi D, Parmentier M.
Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.
Cytokine Growth Factor Rev 17, 501-519, 2006.

Nachtergael I, Gaspard N, Langlet C, Robberecht P and Langer I. 
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: Comparison with Asn216 in VPAC2 receptor.
Cell Signal.; 18(12):2121-2130, 2006.

Paternot S, Dumont JE, Roger PP.
Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Mol Endocrinol 20, 3279-3292, 2006.

Paternot S, Arsenijevic T, Coulonval K, Bockstaele L, Dumont JE, Roger PP
Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3: differential involvement in the distinct mitogenic modes of thyroid epithelial cells
Cell Cycle; Vol.5, Issue 1: 61-70, 2006.

Pesesse X, Backers K, Moreau C, Zhang J, Blero D, Paternotte N, Erneux C.
SHIP1/2 interaction with tyrosine phosphorylated peptides mimicking an immunoreceptor signalling motif.
Adv Enzyme Regul 46, 142-53, 2006.

Roussel C, Erneux C,chiffmann SN,Gall D.
Modulation of neuronal excitability by intracellular calcium buffering : from spiking to bursting. 
Cell Calcium; 39:455-466, 2006.
 
Sadeghi N, Camby I, Goldman S, Gabius HJ, Balériaux D, Salmon I, Decaesteckere C, Kiss R, Metens T.
Effect of hydrophilic components of the extracellular matrix on quantitative diffusion weighted imaging in human gliomas:
preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level.
AJR Am J Roentgenol.;181(1):235-241, 2006.

Sadeghi N, Salmon I, Tang BN, Denolin V, Levivier M, Wikler D, Rorive S, Balériaux D, Metens T, Goldman S.
Correlation between Dynamic Susceptibility Contrast Perfusion MRI and Methionine Metabolism in Brain Gliomas: Preliminary Results.
J mag resonance imag.; 24 (5): 989-994, 2006.
 
Servais C, Caillet-Fauquet P, Draps ML, Velu T, de Launoit Y, Brandenburger A.
Hypoxic-response elements in the oncolytic parvovirus Minute virus of mice do not allow for increased vector production at low oxygen concentration.
J Gen Virol.; 87(Pt5):1197-201, 2006.

Smeesters PR, Vergison A, Campos Junior D, de Aguiar E, Miendje Deyi VY, Van Melderen L.
Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape.
PLoS One 1 (2006) e10.

Smeesters PR, Campos Junior D, Van Melderen L, de Aguiar E, Vanderpas J, Vergison A.
Pharyngitis in low-resources settings: A pragmatic clinical approach to reduce unnecessary antibiotic use.
Pediatrics 118;1607-1611, 2006.

Steuve S, Devosse T, Lauwers E, Vanderwinden JM, Andre B, Courtoy PJ, Pirson I.
Rhophilin-2 is targeted to late-endosomal structures of the vesicular machinery in the presence of activated RhoB.
Exp Cell Res. 312,3981-3989, 2006.

Telleria J, Lafay B, Virreira M, Barnabe C , Tibayrenc M and Svoboda M.
Trypanosoma cruzi: Sequence analysis of the variable region of kinetoplast minicircles.
Exp. Parasitol.; 114(4):279-288, 2006.

Theodoropoulou M, Zhang J, Laupheimer S, Paez-Pereda M, Erneux C, Florio T, Pagotto U, Stalla GK.
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression.
Cancer Res 66, 1576-1582, 2006.

Umubyeyi AN, Martin A, Zissis G, Struelens M, Karita E, Portaels F.
Evaluation of the resazurin microtiter assay for rapid detection of ofloxacin resistance in M. tuberculosis.
Int J Tuberc Lung Dis.;10(7):808-11, 2006.

Van Durme J, Horn F, Costagliola S, Vriend G, Vassart G.
GRIS: Glycoprotein-hormone Receptor Information System.
Mol Endocrinol.; 20(9):2247-2255, 2006. 

Van Eyll JM, Passante L, Pierreux CE, Lemaigre FP, Vanderhaeghen P, Rousseau GG.
Eph receptors and their ephrin ligands are expressed in developing mouse pancreas.
Gene Expr Patterns 6, 353-359, 2006.

Van Staveren WC, Solis DW, Delys L, Venet D, Cappello M, Andry G, Dumont JE, Libert F, Detours V, Maenhaut C.
Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
Proc Natl Acad Sci USA 103, 413-418, 2006.

Vandeput F, Backers K, Villeret V, Pesesse X, Erneux C.
The influence of anionic lipids on SHIP2 phosphatidylinositol 3, 4, 5-trisphosphate 5-phosphatase activity.
Cell Signal 18, 2193-2199, 2006.

Vanderwinden JM, Wang D, Paternotte N, Mignon,S, Isozaki K, Erneux C.
Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
Cell Signal 18, 661-669, 2006.  

Willermain F, Dulku S, Gonzalez NS, Blero D, Driessens G, De Graef C, Caspers L, Bruyns C.
15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism. Prostaglandins Other Lipid Mediat 80, 136-143, 2006.

WOUTERS M, DE LAET A, VER DONCK L, DELPIRE E,VAN BOGAERT PP,TIMMERMANS JP, DE KERCHOVE A, SMANS K, VANDERWINDEN JM.
Subtractive hybridization unravels a role for the ion co-transporter NKCC1 in the murine intestinal pacemaker. 
Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 290:G1219-G1227.

Zhang H, Markadieu N, Beauwens R, Erneux C, Prestwich, G. D.
Synthesis and biological activity of PTEN-resistant analogues of phosphatidylinositol 3, 4, 5-trisphosphate.
J Am Chem Soc. 128, 16464-16465, 2006., 2006.

Bruxelles capitale      EMBO      ERC      FNRS       HFSP       Region Wallonne        Télévie        fondation pour le cancer